U.S. MARKETS FOR INFECTION CONTROL AND BIOSAFETY PRODUCTS

350 Pages | 74 Exhibits | 2010 Analysis | Forecasts Through 2013

OVERVIEW:
Infectious diseases, particularly those acquired in the hospital (nosocomial infections), were among the top 10 causes of death in the U.S. in 2008, as they have been for the past several decades. Bacteria, parasites, and viruses are among the organisms that cause infectious diseases, many of which have only recently been identified. In 2008, U.S. sales of infection control and biosafety products totaled approximately $9.6 billion, with injection devices and related products accounting for an estimated 36% of sales, wound closure devices accounting for 26% of sales, sterilization products accounting for 14% of sales, healthcare-related skin cleansers accounting for 13% of sales, and medical waste disposal supplies accounting for the remaining 11% of sales. Over the forecast period covered by this report, sales of infection control and biosafety products are expected to increase at a compound annual rate of 5.9%, reaching approximately $12.9 billion in the year 2013.

This new 350-page report by Medtech Insight analyzes major market segments for infection control and biosafety products, including nosocomial and community-acquired infection prevention products; injection devices and related products (e.g., skin puncture devices, non-skin puncture devices, and sharps disposal products); handwashes, perioperative skin preparations, and germicides; sterilization equipment, services, and supplies; and wound closure devices. Major topics covered by this report include an overview of infectious organisms and diseases; infectious disease demographics; detailed discussions of the products, markets, and companies associated with infection control and biosafety; a discussion of the clinical applications of infection control; and profiles of the leading companies competing in the U.S. infection control and biosafety products market.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Overview
	a. Bacterial Infections
	b. Parasitic Infections
	c. Proteinacious Infections
	d. Viral Infections
	e. Diagnosis
ii. Infectious Disease Demographics and National Guidelines for Control
	a. Types of Acquired Infections
	b. Impact of Managed Care
	c. Drug Resistance
iii. Nosocomial Infections and Prevention Strategies
	a. Prevention Techniques
	b. Medical Waste Disposal
	c. Ventilation Systems Management
	d. Market Analysis
iv. Injection Devices and Related Products
	a. Skin Puncture Devices
	b. Non-Skin Puncture Devices
	c. Sharps Disposal Products
	d. Market Analysis
v. Handwashes, Perioperative Skin Preparations, and Germicides
	a. Handwashes and Surgical Scrubs
	b. Disinfectants and Germicides
	c. Market Analysis
vi. Sterilization Equipment, Services, and Supplies
	a. Sterilization Equipment
	b. Sterilization Services
	c. Sterilization Supplies
	d. Market Analysis
vii. Wound Closure Products
	a. Staples
	b. Sutures
	c. Wound Closure Strips
	d. Automated Suturing Devices
	e. Energy-Based Wound Closure Products
	f. Surgical Sealants and Glues
	g. Market Analysis
viii. Combined Market Analysis

Exhibit ES-1: Medical Waste Disposal and Portable Air Filtration Products, Market Forecast, 2008-2013
Exhibit ES-2: Injection Devices and Related Products, Market Forecast, 2008-2013
Exhibit ES-3: Handwashes, Perioperative Skin Preparations, and Germicides, Market Forecast, 2008-2013
Exhibit ES-4: Sterilization Equipment, Services, and Supplies, Market Forecast, 2008-2013
Exhibit ES-5: Traditional and Emerging Wound Closure Devices, Market Forecast, 2008-2013
Exhibit ES-6: Infection Control and Biosafety Products, Combined Market Forecast, 2008-2013

1. OVERVIEW OF INFECTIOUS ORGANISMS AND DISEASES

1.1 Bacterial Infections
	1.1.1 Anthrax
	1.1.2 Botulism
	1.1.3 Brucellosis
	1.1.4 Cholera
	1.1.5 Diphtheria
	1.1.6 Diseases Associated with Acinetobacter baumannii spp.
	1.1.7 Diseases Associated with Clostridium difficile spp.
	1.1.8 Diseases Associated with Haemophilus spp.
	1.1.9 Diseases Associated with Helicobacter pylori spp.
	1.1.10 Diseases Associated with Mycobacteria spp.
	1.1.11 Diseases Associated with Pseudomonas spp.
	1.1.12 Diseases Associated with Staphylococcus spp.
	1.1.13 Diseases Associated with Streptococcus spp.
	1.1.14 Escherichia coli Infection
	1.1.15 Gonorrhea/Meningitis
	1.1.16 Legionnaires' Disease
	1.1.17 Listeriosis
	1.1.18 Lyme Disease
	1.1.19 Nocardiosis
	1.1.20 Salmonella
	1.1.21 Tularemia
	1.1.22 Yersiniosis
1.2 Parasitic Infections
	1.2.1 Giardiasis
	1.2.2 Roundworm
		1.2.2.1 Ascariasis
		1.2.2.2 Hookworm
		1.2.2.3 Pinworm
		1.2.2.4 Whipworm
	1.2.3 Tapeworm
1.3 Proteinaceous Infections
	1.3.1 Bovine Spongiform Encephalopathy
		1.3.1.1 New Variant Creutzfeldt-Jakob Disease
1.4 Viral Infections
	1.4.1 Dysentery
	1.4.2 Encephalitis
		1.4.2.1 Japanese Encephalitis
	1.4.3 Hemorrhagic Fever
	1.4.4 Hepatitis
		1.4.4.1 Hepatitis A
		1.4.4.2 Hepatitis B
		1.4.4.3 Hepatitis C
		1.4.4.4 Hepatitis D
		1.4.4.5 Hepatitis E
	1.4.5 Herpes
		1.4.5.1 Herpes Simplex
		1.4.5.2 Herpes Zoster
	1.4.6 Human Immunodeficiency Virus
	1.4.7 Human Papillomavirus and Cervical Cancer
	1.4.8 Influenza
		1.4.8.1 Avian Influenza
		1.4.8.2 Porcine Influenza
	1.4.9 Measles
	1.4.10 Mononucleosis
	1.4.11 Mumps
	1.4.12 Respiratory Syncytial Virus
	1.4.13 Parvovirus and Fifth Disease
	1.4.14 Poliomyelitis
	1.4.15 Protozoa
	1.4.16 Varicella
	1.4.17 Variola
1.5 Diagnosis
	1.5.1 Bacterial Infection Diagnosis
	1.5.2 Parasitic Infection Diagnosis
	1.5.3 Viral Infection Diagnosis
	1.5.4 Other Diagnostic Tests
		1.5.4.1 Imaging
		1.5.4.2 Invasive Tests
		1.5.4.3 Smears

Exhibit 1-1: Selected Diseases, Causes of Emergence, and Modes of Transmission
Exhibit 1-2: Selected Biological Diseases and Agents, by Category
Exhibit 1-3: Selected Herpesviruses
Exhibit 1-4: Selected Bacterial Infections, Symptoms, and Diagnostic Tests
Exhibit 1-5: Selected Parasitic Infections, Symptoms, and Diagnostic Tests
Exhibit 1-6: Selected Viral Infections, Symptoms, and Diagnostic Tests

2. INFECTIOUS DISEASE DEMOGRAPHICS AND NATIONAL GUIDELINES FOR CONTROL

2.1 Demographics Overview
	2.1.1 High Risk Populations
		2.1.1.1 Acute Healthcare
			2.1.1.1.1 Patients
			2.1.1.1.2 Healthcare Workers
		2.1.1.2 Long-Term Healthcare
			2.1.1.2.1 Patients
			2.1.1.2.2 Healthcare Workers
		2.1.1.3 Home Healthcare
			2.1.1.3.1 Patients
			2.1.1.3.2 Care Providers
	2.1.2 Types of Acquired Infections
		2.1.2.1 Airborne Pathogens
		2.1.2.2 Bloodborne Pathogens
		2.1.2.3 Surface Borne Pathogens
	2.1.3 Impact of Managed Care
	2.1.4 Drug Resistance
		2.1.4.1 Methicillin-Resistant Staphylococcus aureus
		2.1.4.2 Vancomycin-Resistant Enterococci
		2.1.4.3 Influenza
		2.1.4.4 Types of Microbes and Viruses
		2.1.4.5 Impact on Cost of Care
	2.1.5 Technological Developments
2.2 National Guidelines Overview
	2.2.1 American Association of periOperative Registered Nurses
	2.2.2 American Nurses Association
	2.2.3 American Society for Healthcare Central Service Professionals
	2.2.4 Association for the Advancement of Medical Instrumentation
	2.2.5 Association for Professionals in Infection Control and Epidemiology
	2.2.6 Centers for Disease Control and Prevention
		2.2.6.1 National Institute for Occupational Safety and Health
	2.2.7 International Association of Healthcare Central Service Material Management
	2.2.8 The Joint Commission
	2.2.9 Occupational Safety and Health Administration
	2.2.10 Service Employees International Union
	2.2.11 Society for Healthcare Epidemiology of America
	2.2.12 United States Food and Drug Administration

Exhibit 2-1: Population Distribution, by Age, 1990, 2000, 2010, and 2020
Exhibit 2-2: Lengths of Stay in Nonfederal, Short-Stay Hospitals, 1970, 1985, 1995, and 2005
Exhibit 2-3: 2010, Selected Occupationally Acquired Infections, by Area of Employment
Exhibit 2-4: 2010, Selected Occupationally Acquired Infections, by Mode of Disease Transmission

3. NONSOCOMIAL INFECTIONS AND PREVENTION STRATEGIES

3.1 Overview
	3.1.1 Epidemiology
	3.1.2 Transmission
3.2 National Healthcare Safety Network
	3.2.1 High-Risk Delivery Areas
		3.2.1.1 Intensive Care Unit Infection Rates
			3.2.1.1.1 Bloodstream Infections
			3.2.1.1.2 Respiratory Tract Infections
			3.2.1.1.3 Surgical Site Infections
			3.2.1.1.4 Urinary Tract Infections
		3.2.1.2 Device-Related Infections
		3.2.1.3 Hospital Practices-Related Infections
	3.2.2 Mortality Rates
	3.2.3 Related Costs
	3.2.4 Prevention Strategies
		3.2.4.1 Bundling
		3.2.4.2 Benchmarking Best Practices
3.3 Nosocomial Infection Prevention Techniques
	3.3.1 Skin Preparation
		3.3.1.1 Handwashing
			3.3.1.1.1 Touchless Technology
		3.3.1.2 Perioperative Patient Skin Preparation
		3.3.1.3 Surgical Scrubbing
	3.3.2 Safety Needles
	3.3.3 Infection-Resistant Products
	3.3.4 Cleaning, Disinfection, and Sterilization
		3.3.4.1 Cleaning
			3.3.4.1.1 Manual Scrubbing
			3.3.4.1.2 Ultrasonic Cleaning
		3.3.4.2 Disinfection
			3.3.4.2.1 Liquid Chemicals
			3.3.4.2.2 Dry Chemicals
		3.3.4.3 Sterilization
			3.3.4.3.1 Autoclaving
			3.3.4.3.2 Ethylene Oxide
			3.3.4.3.3 Flash Sterilization
			3.3.4.3.4 Gamma Radiation
			3.3.4.3.5 Hydrogen Peroxide
			3.3.4.3.6 Microwave
			3.3.4.3.7 Ozone
			3.3.4.3.8 Peracetic Acid
	3.3.5 Catheter Site Care
	3.3.6 Antimicrobial Barriers
	3.3.7 Handling and Disposal of Medical Waste
		3.3.7.1 Products and Technology
			3.3.7.1.1 Autoclaving
			3.3.7.1.2 Chemical Disposal
			3.3.7.1.3 Incineration
			3.3.7.1.4 Microwaving
			3.3.7.1.5 Plasma Pyrolysis
		3.3.7.2 Market Analysis
	3.3.8 Ventilation Systems Management
		3.3.8.1 Air Filtration Systems
			3.3.8.1.1 Products and Technologies
			3.3.8.1.2 Market Forecast
		3.3.8.2 Indoor Air Quality Monitoring Systems
			3.3.8.2.1 Products and Technologies
		3.3.8.3 Sterilizing Vapor Systems
	3.3.9 Single-Patient-Use versus Reusable Medical Devices
		3.3.9.1 Multiple Use of Single-Patient-Use Medical Devices
			3.3.9.1.1 Products and Technologies
			3.3.9.1.2 Market Analysis
	3.3.10 Automated Patient Surveillance
		3.3.10.1 Products and Technologies
		3.3.10.2 Market Analysis

Exhibit 3-1: 2008, Device-Associated Infection Rates, by Setting
Exhibit 3-2: Nosocomial Infection Prevention Strategies
Exhibit 3-3: Advantages and Disadvantages of Selected Sterilization Technologies
Exhibit 3-4: Medical Waste Disposal Products and Services, Market Forecast, 2008-2013
Exhibit 3-5: OSHA Air Quality Guidelines
Exhibit 3-6: 2010, Selected Air Filtration Products
Exhibit 3-7: Portable Air Filtration Products, Market Forecast, 2008-2013
Exhibit 3-8: 2010, Selected Indoor Air Quality Monitoring Systems

4. INJECTION DEVICES AND RELATED PRODUCTS

4.1 Overview
4.2 Skin Puncture Devices
	4.2.1 Regulations and Guidelines
		4.2.1.1 Federal Legislation
		4.2.1.2 State Legislation
	4.2.2 Needlestick Prevention
		4.2.2.1 Dialysis Centers
	4.2.3 Products and Technologies
	4.2.4 Market Analysis
		4.2.4.1 Disposable Needles and Syringes
			4.2.4.1.1 Competitive Analysis
		4.2.4.2 Safety Needles and Syringes
			4.2.4.2.1 Competitive Analysis
			4.2.4.2.2 Hinged Cover Syringes
			4.2.4.2.3 Retractable Syringes
			4.2.4.2.4 Other Products
		4.2.4.3 Phlebotomy and Venipuncture Needle Devices
4.3 Non-Skin Puncture Devices
	4.3.1 Products and Technologies
	4.3.2 Market Analysis
	4.3.3 Competitive Analysis
4.4 Alternatives to Traditional Injection Systems
	4.4.1 Products and Technologies
		4.4.1.1 Auto-Injectors
		4.4.1.2 Inhalation Drug Delivery
		4.4.1.3 Oral Drug Delivery
		4.4.1.4 Iontophoresis
		4.4.1.5 Powder Injection
		4.4.1.6 Transdermal Drug Delivery
4.5 Sharps Disposal Products
	4.5.1 Regulations and Guidelines
	4.5.2 Products and Technologies
	4.5.3 Market Analysis
4.6 Combined Market Forecast

Exhibit 4-1: 2010, Needlestick Safety Devices, by Type
Exhibit 4-2: Skin Puncture Devices, Market Forecast, 2008-2013
Exhibit 4-3: 2009, Standard Disposable Needles and Syringes Market, Share by Supplier
Exhibit 4-4: 2010, Selected Safety Needles and Syringes
Exhibit 4-5: 2009, Safety Needles and Syringes Market, Share by Supplier
Exhibit 4-6: Non-Skin Puncture Devices, Market Forecast, 2008-2013
Exhibit 4-7: 2009, Non-Skin Puncture Devices Market, Share by Supplier
Exhibit 4-8: OSHA Criteria for Sharps Disposable Container Safety
Exhibit 4-9: Sharps Disposal Containers, Market Forecast, 2008-2013
Exhibit 4-10: Injection Devices and Related Products, Combined Market Forecast, 2008-2013

5. HANDWASHES, PERIOPERATIVE SKIN PREPARATIONS, AND GERMICIDES

5.1 Handwashes and Perioperative Skin Preparations
	5.1.1 Handwashes and Surgical Scrubs
		5.1.1.1 Guidelines
		5.1.1.2 Compliance
		5.1.1.3 Products and Technologies
			5.1.1.3.1 Hygienic Handwashes
			5.1.1.3.2 Surgical Scrubs
		5.1.1.4 Market Analysis
	5.1.2 Perioperative Skin Preparations
		5.1.2.1 Products
		5.1.2.2 Market Analysis
	5.1.3 Handwashes and Perioperative Skin Preparations, combined Market Analysis
5.2 Disinfectants and Germicides
	5.2.1 Products
		5.2.1.1 High-Level Disinfectants
			5.2.1.1.1 Market Analysis
		5.2.1.2 Low-Level Disinfectants
			5.2.1.2.1 Market Analysis
	5.2.2 Disinfectants and Germicides, Combined Market Analysis
5.3 Handwashes, Perioperative Skin Preparations, and Germicides, Combined Market Analysis

Exhibit 5-1: Healthcare Hand Antisepsis Product Categories
Exhibit 5-2: 2010, Selected Antimicrobials Used for Hand Antisepsis
Exhibit 5-3: 2010, Selected Handwashing Products
Exhibit 5-4: 2010, Selected Antimicrobial Hand Scrub Products
Exhibit 5-5: Handwashes and Surgical Scrubs, Market Forecast, 2008-2013
Exhibit 5-6: 2010, Selected Perioperative Skin Preparation Products
Exhibit 5-7: Perioperative Skin Preparations, Market Forecast, 2008-2013
Exhibit 5-8: Handwashes and Perioperative Skin Preparations, Combined Market Forecast, 2008-2013
Exhibit 5-9: 2009, Handwashes and Perioperative Skin Preparations Market, Share by Supplier
Exhibit 5-10: 2010, Selected High-Level Disinfectants
Exhibit 5-11: High-Level Disinfectants, Market Forecast, 2008-2013
Exhibit 5-12: 2010, Selected Low-Level Disinfectants
Exhibit 5-13: Low-Level Disinfectants, Market Forecast, 2008-2013
Exhibit 5-14: Disinfectants and Germicides, Combined  Market Forecast, 2008-2013
Exhibit 5-15: Handwashes, Perioperative Skin Preparations, and Germicides, Combined Market Forecast, 2008-2013

6. STERILIZATION EQUIPMENT, SERVICES, AND SUPPLIES

6.1 Sterility Assurance Level
6.2 Technology
6.2.1 Flash Sterilization
6.3 Equipment
	6.3.1 Instrument Sterilizers
		6.3.1.1 Regulations and Guidelines
		6.3.1.2 Products and Technology
		6.3.1.3 Market Analysis
	6.3.2 Room Sterilizers
		6.3.2.1 Market Analysis
6.4 Services
	6.4.1 Contract Sterilization
		6.4.1.1 Market Analysis
6.5 Supplies
	6.5.1 Products and Technology
	6.5.2 Market Analysis
6.6 Combined Market Analysis

Exhibit 6-1: Comparison of Selected Sterilization Methods
Exhibit 6-2: 2010, Selected Sterilization Products
Exhibit 6-3: Sterilization Equipment, Market Forecast, 2008-2013
Exhibit 6-4: Contract Sterilization Services, Market Forecast, 2008-2013
Exhibit 6-5: Sterilization Supplies, Market Forecast, 2008-2013
Exhibit 6-6: Sterilization Equipment, Services, and Supplies, Combined Market Forecast, 2008-2013
Exhibit 6-7: 2009, Sterilization Equipment, Services, and Supplies Market, Share by Supplier

7. WOUND CLOSURE PRODUCTS

7.1 Skin Structure
	7.1.1 Skin Wounds
7.2 Traditional Wound Closure Products and Technologies
	7.2.1 Staples
		7.2.1.1 Market Analysis
		7.2.1.2 Competitive Analysis
	7.2.2 Sutures
		7.2.2.1 Market Analysis
		7.2.2.2 Competitive Analysis
	7.2.3 Wound Closure Strips
		7.2.3.1 Market Analysis
		7.2.3.2 Competitive Analysis
7.3 Emerging Wound Closure Products and Technologies
	7.3.1 Automated Suturing Devices
		7.3.1.1 Market Analysis
		7.3.1.2 Competitive Analysis
	7.3.2 Energy-Based Wound Closure Products
		7.3.2.1 Market Analysis
		7.3.2.2 Competitive Analysis
	7.3.3 Surgical Sealants and Glues
		7.3.3.1 Market Analysis
		7.3.3.2 Competitive Analysis
7.4 Combined Market Analysis

Exhibit 7-1: The Skin's Layers and Supporting Structures
Exhibit 7-2: Major Wound Types, by Cause
Exhibit 7-3: 2006, Inpatient Surgery, Procedure Volumes
Exhibit 7-4: 2007, Incidence of Major Wound Types
Exhibit 7-5: Surgical Stapling Products, Market Forecast, 2008-2013
Exhibit 7-6: 2009, Surgical Stapling Products Market, Share by Supplier
Exhibit 7-7: Sutures, Market Forecast, 2008-2013
Exhibit 7-8: 2009, Sutures Market, Share by Supplier
Exhibit 7-9: Wound Closure Strips, Market Forecast, 2008-2013
Exhibit 7-10: 2009, Wound Closure Strips Market, Share by Supplier
Exhibit 7-11: Automated Suturing Devices, Market Forecast, 2008-2013
Exhibit 7-12: 2009, Automated Suturing Devices Market, Share by Supplier
Exhibit 7-13: Energy-Based Closure Devices, Market Forecast, 2008-2013
Exhibit 7-14: 2009, Energy-Based Closure Devices Market, Share by Supplier
Exhibit 7-15: Modes of Action for Surgical Sealants and Glues
Exhibit 7-16: Surgical Sealants and Glues, Market Forecast, 2008-2013
Exhibit 7-17: 2009, Surgical Sealants and Glues Market, Share by Supplier
Exhibit 7-18: Traditional and Emerging Wound Closure Devices, Combined Market Forecast, 2008-2013

8. COMPANY PROFILES

8.1 3M Health Care/3M Company
8.2 C.R. Bard, Inc.
8.3 Baxter Healthcare Corporation/Baxter International, Inc.
8.4 B. Braun Melsungen AG
8.5 Becton, Dickinson and Company
8.6 Covidien PLC
8.7 Getinge USA, Inc./Getinge Group AB
8.8 Johnson & Johnson
8.9 Olympus America, Inc./Olympus Corporation
8.10 Purdue Pharma LP
8.11 Smiths Medical/Smiths Group PLC
8.12 STERIS Corporation

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. 3M Health Care/3M Company
  2. C.R. Bard, Inc.
  3. Baxter Healthcare Corporation/Baxter International, Inc.
  4. B. Braun Melsungen AG
  5. Becton, Dickinson and Company
  6. Covidien PLC
  7. Getinge USA, Inc./Getinge Group AB
  8. Johnson & Johnson
  9. Olympus America, Inc./Olympus Corporation
  10. Purdue Pharma LP
  11. Smiths Medical/Smiths Group PLC
  12. STERIS Corporation
Contact Us

Need help finding medtech research? Let us help you!